BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16258723)

  • 1. Reversal of maladaptive gene program in left ventricular myocardium of dogs with heart failure following long-term therapy with the Acorn Cardiac Support Device.
    Rastogi S; Mishra S; Gupta RC; Sabbah HN
    Heart Fail Rev; 2005 Jun; 10(2):157-63. PubMed ID: 16258723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cardiac support device on reverse remodeling: molecular, biochemical, and structural mechanisms.
    Sabbah HN
    J Card Fail; 2004 Dec; 10(6 Suppl):S207-14. PubMed ID: 15803552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global left ventricular remodeling with the Acorn Cardiac Support Device: hemodynamic and angiographic findings in dogs with heart failure.
    Sabbah HN
    Heart Fail Rev; 2005 Jun; 10(2):109-15. PubMed ID: 16258718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular histomorphometric findings in dogs with heart failure treated with the Acorn Cardiac Support Device.
    Sharov VG; Todor AV; Sabbah HN
    Heart Fail Rev; 2005 Jun; 10(2):141-7. PubMed ID: 16258721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment.
    Sabbah HN; Sharov VG; Gupta RC; Mishra S; Rastogi S; Undrovinas AI; Chaudhry PA; Todor A; Mishima T; Tanhehco EJ; Suzuki G
    Circ Res; 2003 Nov; 93(11):1095-101. PubMed ID: 14563716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of cardiac sarcoplasmic reticulum calcium cycling in dogs with heart failure following long-term therapy with the Acorn Cardiac Support Device.
    Gupta RC; Mishra S; Rastogi S; Sharov VG; Sabbah HN
    Heart Fail Rev; 2005 Jun; 10(2):149-55. PubMed ID: 16258722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy with the acorn cardiac support device normalizes gene expression of growth factors and gelatinases in dogs with heart failure.
    Rastogi S; Gupta RC; Mishra S; Morita H; Tanhehco EJ; Sabbah HN
    J Heart Lung Transplant; 2005 Oct; 24(10):1619-25. PubMed ID: 16210139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute ventricular reduction with the acorn cardiac support device: effect on progressive left ventricular dysfunction and dilation in dogs with chronic heart failure.
    Chaudhry PA; Anagnostopouls PV; Mishima T; Suzuki G; Nair H; Morita H; Sharov VG; Alferness C; Sabbah HN
    J Card Surg; 2001; 16(2):118-26. PubMed ID: 11766829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial reverse remodeling in dogs with moderate and advanced heart failure treated with a passive mechanical containment device: an echocardiographic study.
    Zacà V; Brewer R; Khanal S; Imai M; Jiang A; Wang M; Goldstein S; Sabbah HN
    J Card Fail; 2007 May; 13(4):312-7. PubMed ID: 17517352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure.
    Hutchinson KR; Guggilam A; Cismowski MJ; Galantowicz ML; West TA; Stewart JA; Zhang X; Lord KC; Lucchesi PA
    J Appl Physiol (1985); 2011 Dec; 111(6):1778-88. PubMed ID: 21885799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiac support device and the myosplint: treating heart failure by targeting left ventricular size and shape.
    Sabbah HN
    Ann Thorac Surg; 2003 Jun; 75(6 Suppl):S13-9. PubMed ID: 12820730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.
    Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J
    J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term pharmacological activation of PPARgamma does not prevent left ventricular remodeling in dogs with advanced heart failure.
    Suzuki G; Khanal S; Rastogi S; Morita H; Mishima T; Anagnostopoulos PV; Nass O; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
    Cardiovasc Drugs Ther; 2007 Feb; 21(1):29-36. PubMed ID: 17294127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial.
    Starling RC; Jessup M; Oh JK; Sabbah HN; Acker MA; Mann DL; Kubo SH
    Ann Thorac Surg; 2007 Oct; 84(4):1236-42. PubMed ID: 17888975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure.
    Imai M; Rastogi S; Gupta RC; Mishra S; Sharov VG; Stanley WC; Mika Y; Rousso B; Burkhoff D; Ben-Haim S; Sabbah HN
    J Am Coll Cardiol; 2007 May; 49(21):2120-8. PubMed ID: 17531662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biventricular finite element modeling of the Acorn CorCap Cardiac Support Device on a failing heart.
    Wenk JF; Ge L; Zhang Z; Mojsejenko D; Potter DD; Tseng EE; Guccione JM; Ratcliffe MB
    Ann Thorac Surg; 2013 Jun; 95(6):2022-7. PubMed ID: 23643546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy.
    Mann DL; Acker MA; Jessup M; Sabbah HN; Starling RC; Kubo SH;
    Ann Thorac Surg; 2007 Oct; 84(4):1226-35. PubMed ID: 17888974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support.
    Rodrigue-Way A; Burkhoff D; Geesaman BJ; Golden S; Xu J; Pollman MJ; Donoghue M; Jeyaseelan R; Houser S; Breitbart RE; Marks A; Acton S
    J Heart Lung Transplant; 2005 Jan; 24(1):73-80. PubMed ID: 15653383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic therapy with cardiac contractility modulation electrical signals on cytoskeletal proteins and matrix metalloproteinases in dogs with heart failure.
    Rastogi S; Mishra S; Zacà V; Mika Y; Rousso B; Sabbah HN
    Cardiology; 2008; 110(4):230-7. PubMed ID: 18073477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.